Resources
From Chance Discovery to Molecular Biology
Dr. Sheldon H. Preskorn's presentation, "From Chance Discovery to Molecular Biology," highlights the evolution of ...
Accelerating Clinical & Drug Development Timelines with AI
As the drug development landscape rapidly evolves, artificial intelligence (AI) is emerging as a transformative force, ...
Updates on Human Abuse Potential Studies: Challenges and Regulatory Guidelines
Discover this groundbreaking webinar delving into the latest insights from the CCALC and the FDA in drug development and clinical evaluation of human drug abuse and dependence potential.